NCT04619030 is a NA clinical trial of Augmented Reality in Sarcoma, sponsored by NHS Greater Glasgow and Clyde.

Who is sponsoring NCT04619030?

NCT04619030 is sponsored by NHS Greater Glasgow and Clyde.

What drugs are being tested in NCT04619030?

Interventions in NCT04619030: Augmented Reality, Traditional leaflet.

What condition does NCT04619030 study?

NCT04619030 studies Sarcoma, Breast Cancer, Cleft Lip and Palate, Surgical Flap.

Is NCT04619030 still recruiting?

NCT04619030 is currently status unknown. Last updated 10 June 2021.

Last reviewed 2021-06-10 · How we verify

NCT04619030

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Augmented Reality (AR): The Future of "Patient Information Leaflets

Status unknown NA Last updated 10 June 2021

What this trial tests

NA trial testing Augmented Reality in Sarcoma in 20 participants. Status unknown.

Timeline

30 November 2020

Primary endpoint
30 December 2021

30 March 2022

Quick facts

Lead sponsor	NHS Greater Glasgow and Clyde
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	other
Enrollment	20
Start date	30 November 2020
Primary completion	30 December 2021
Estimated completion	30 March 2022
Sites	3 locations across United Kingdom

Drugs / interventions tested

Augmented Reality
Traditional leaflet

Conditions studied

Sarcoma — all drugs for Sarcoma →
Breast Cancer — all drugs for Breast Cancer →
Cleft Lip and Palate — all drugs for Cleft Lip and Palate →
Surgical Flap — all drugs for Surgical Flap →

Sponsor

NHS Greater Glasgow and Clyde — full company profile →

Who can join

Adults 16 to 90, any sex, with Sarcoma or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project aims to assess a new type of Augmented Reality Patient Information leaflet, in order to demonstrate that it is a beneficial information resource to patients when facing the diagnosis of sarcoma, breast cancer or to explain difficult concepts such as cleft lip repair. There are no published studies on the use of AR in patient leaflets.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Cleft Lip Education with Augmented Reality (CLEAR) VR Phase 2 Trial: A Pilot Randomized Crossover Trial of a Novel Patient Information Leaflet.
Lo SJ, Chapman P, Young D, Drake D, et al · · 2023 · cited 4× · PMID 34982018 · DOI 10.1177/10556656211059709

Verify or expand the search:

Other trials of Augmented Reality

Trials testing the same drug.

NCT07112417 — "Augmented Reality-Assisted Miniscrew Placement in Orthodontics: A Clinical Trial" · NA · not yet recruiting
NCT07113093 — The Effects of Augmented Reality Versus Virtual Reality · NA · recruiting
NCT06761781 — Augmented Reality for Stroke Rehabilitation · NA · completed
NCT05885334 — Caregivers Training Using Artificial Intelligence and Virtual Reality · NA · completed
NCT06986655 — The Effect of an Augmented Reality Game on Pain, Fear, and Care Satisfaction Levels During Allergy Testing in Children A · NA · completed

Other recruiting trials for Sarcoma

Currently open trials in the same condition.

NCT07402577 — Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot · recruiting
NCT07501026 — Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC) · Phase 2 · recruiting
NCT07359911 — Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patient · NA · recruiting
NCT07410676 — EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
NCT07222735 — Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcoma · Phase 1 · recruiting

Other NHS Greater Glasgow and Clyde trials

Trials by the same sponsor.

NCT07403890 — Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis · NA · not yet recruiting
NCT07372508 — Glasgow Low-dose CT and AI-based Diagnostics to Case Find Lung Cancer and Other Cardio-respiratory Long-term Conditions · NA · not yet recruiting
NCT07391280 — Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department · NA · not yet recruiting
NCT07048184 — Sarcoma Surgery Wound Complications Comparing Usual Versus Negative Pressure Dressing · Phase 2 · not yet recruiting
NCT06786936 — Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04619030 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NHS Greater Glasgow and Clyde
Last refreshed: 10 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04619030.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing